ClinVar Miner

Submissions for variant NM_014249.4(NR2E3):c.925C>G (p.Arg309Gly)

dbSNP: rs774102273
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001379522 SCV001577334 pathogenic not provided 2024-02-26 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 309 of the NR2E3 protein (p.Arg309Gly). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This missense change has been observed in individuals with clinical features of autosomal recessive enhanced S-cone syndrome (PMID: 10655056, 15459973, 19718767; Invitae). ClinVar contains an entry for this variant (Variation ID: 1068080). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on NR2E3 protein function. Experimental studies have shown that this missense change affects NR2E3 function (PMID: 19898638, 24069298, 25703721, 28300834). For these reasons, this variant has been classified as Pathogenic.
Baylor Genetics RCV001831369 SCV005053701 pathogenic Enhanced S-cone syndrome 2024-02-07 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV005057350 SCV005726328 pathogenic Retinitis pigmentosa 2024-11-14 criteria provided, single submitter clinical testing Variant summary: NR2E3 c.925C>G (p.Arg309Gly) results in a non-conservative amino acid change located in the Nuclear receptor (NR) ligand-binding (LBD) domain (IPR000536) of the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.1e-06 in 242578 control chromosomes. c.925C>G has been reported in the literature in compound heterozygous individuals affected with autosomal recessive Enhanced S-cone syndrome (Haider_2000, Wright_2004, daPalma_2022, Schorderet_2009, Galantuomo_2008, Invitae). These data indicate that the variant is very likely to be associated with disease. Several publications report experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in partial mislocalization of the mutant protein to cytoplasm, loss of DNA binding activity and reduced dimerazation and transcription activity of heterodimers (Fradot_2007, Kanda_2009, von Alpen_2015). The following publications have been ascertained in the context of this evaluation (PMID: 17438525, 28300834, No PMID, 10655056, 19898638, 19718767, 15459973, 36067420, 25703721). ClinVar contains an entry for this variant (Variation ID: 1068080). Based on the evidence outlined above, the variant was classified as pathogenic.
Natera, Inc. RCV001831369 SCV002085629 likely pathogenic Enhanced S-cone syndrome 2020-07-08 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV004531189 SCV004744620 likely pathogenic NR2E3-related disorder 2023-10-20 no assertion criteria provided clinical testing The NR2E3 c.925C>G variant is predicted to result in the amino acid substitution p.Arg309Gly. This variant was reported in at least one individual with autosomal recessive enhanced S-cone syndrome (Haider. 2000. PubMed ID: 10655056; Wright. 2004. PubMed ID: 15459973; Schorderet. 2009. PubMed ID: 19718767) with in vitro experiments finding this variant affects protein function (Kanda. 2009. PubMed ID: 19898638; von Alpen. 2015. PubMed ID: 25703721; Fradot. 2007. PubMed ID: 17438525; Tan. 2013. PubMed ID: 24069298). This variant is reported in 0.00090% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/15-72105906-C-G). This variant is interpreted as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.